J&J Talcum Powder Ovarian Cancer Lawsuit: MDL 2738, the Texas Two-Step, and What Claimants Need to Know Now

Most people assume that because Johnson & Johnson stopped selling talc-based baby powder in North America in 2020 (and globally in 2023), the litigation is winding down. The opposite is true. As of April 2026, tens of thousands of claims remain pending in federal court under MDL 2738, and a high-stakes battle over J&J’s bankruptcy strategy has added a layer of complexity that makes this one of the most closely watched product liability cases in modern US history.

If you or a family member used J&J talcum powder products over many years and have been diagnosed with ovarian cancer or mesothelioma, this article explains the structure of the litigation, the statute of limitations risks that catch many claimants off guard, and the specific corporate maneuver J&J deployed to try to limit its exposure.

The Two Legal Theories at the Core of MDL 2738

The talc litigation rests on two distinct theories, and knowing which one applies to your situation matters.

Theory One: Asbestos Contamination → Mesothelioma

Talc and asbestos are naturally occurring minerals that can share the same geological formations. The WHO’s International Agency for Research on Cancer (IARC) classifies asbestos-containing talc as Group 1, a confirmed carcinogen in humans. Internal J&J documents and testing records introduced during litigation raised questions about whether the company’s talc products contained asbestos at various points in their history. Women diagnosed with mesothelioma who had significant talc product use history are at the center of this theory.

Mesothelioma has a long latency period, typically 20 to 50 years between exposure and diagnosis. This means women who used talc products in the 1970s, 1980s, or 1990s are only now receiving diagnoses in some cases. That latency is precisely why “it’s too late” is often the wrong assumption.

Theory Two: Perineal Talc Use → Ovarian Cancer

Separate from the asbestos question, a body of epidemiological research spanning decades has examined whether regular perineal application of talcum powder increases ovarian cancer risk. J&J has consistently denied this causal link, and the science remains contested. Nevertheless, juries in bellwether trials have found in plaintiffs’ favor, and internal company marketing and research documents have featured prominently in trial evidence.

These two theories involve different diagnoses, different causation arguments, and somewhat different evidentiary burdens, but both are routed through MDL 2738 in the District of New Jersey.

How MDL 2738 Actually Works

Multidistrict Litigation is routinely misunderstood. It is not a class action. This distinction has real consequences for claimants.

In a class action, a single judgment or settlement binds all class members. In an MDL, individual cases retain their separate identity. What MDL does is consolidate pre-trial proceedings (discovery, expert witness challenges, motions practice) before a single federal judge to avoid duplicative work across thousands of cases.

The MDL judge for the J&J talc litigation oversees coordinated discovery, rules on common legal questions, and may supervise “bellwether” trials, which are individual cases selected to test how juries respond to the evidence. Bellwether outcomes inform settlement negotiations for the broader pool of cases.

After centralized pre-trial work is complete, individual cases that have not settled are remanded to their home federal districts for trial. In practice, the overwhelming majority of MDL cases resolve through settlement before reaching that stage.

The practical upshot for claimants: filing a claim in MDL 2738 does not mean you will personally go to trial. It means your case is coordinated with thousands of others, sharing the benefits of common discovery and legal work, while your individual damages (your specific diagnosis, treatment costs, lost income, pain and suffering) remain your own.

Mesothelioma Lawsuit Compensation →

The Texas Two-Step: J&J’s Attempt to Limit Exposure

No single development has shaped the talc litigation more than J&J’s use of a bankruptcy strategy critics call the “Texas Two-Step.”

Here is the structure. Texas law permits a corporate division that allows a company to split into two entities, assigning specific liabilities to one while the assets remain with the other. J&J used this mechanism to create LTL Management, a subsidiary that received J&J’s talc-related litigation liabilities. LTL then filed for Chapter 11 bankruptcy protection in 2021.

The strategic goal was to invoke bankruptcy’s automatic stay, a provision that halts most legal proceedings against a debtor, to pause the tens of thousands of individual talc lawsuits pending against J&J. By routing the liability through LTL, J&J hoped to resolve claims through a bankruptcy trust at a capped total rather than face open-ended jury verdicts.

The Third Circuit Court of Appeals rejected this maneuver. The court found that LTL Management was not in genuine financial distress, which is a fundamental requirement for bankruptcy protection under controlling legal principles. With J&J as its financial backer, LTL could pay claims without filing bankruptcy at all. The court dismissed the bankruptcy case.

J&J has not abandoned this approach entirely. Subsequent maneuvering has continued, and the litigation over the viability of this strategy is itself still evolving. The key practical point for claimants: the bankruptcy strategy has not succeeded in extinguishing claims, and individual cases continue to move through MDL 2738. But the status can shift, which is why claimants should check current court filings through PACER or with their attorney rather than relying on general summaries.

Statute of Limitations: The Trap Most Claimants Don’t See Coming

The single biggest mistake talc claimants make is assuming they are too late without actually checking their state’s rules.

Statutes of limitations for product liability claims vary significantly by state, commonly ranging from one to six years. But the critical factor is when that clock starts. Most states apply some version of the discovery rule: the limitations period begins when the plaintiff knew, or through reasonable diligence should have known, that they were harmed and that the defendant’s product may have caused that harm.

For a disease like mesothelioma or ovarian cancer that can develop decades after exposure, this means the clock typically starts at or around diagnosis, not when you last used the product. A woman who stopped using talc powder in 1995 but was diagnosed with ovarian cancer in 2024 may have been within her state’s filing window as recently as 2025 or 2026, depending on her state.

Some states have additional nuances. California, New York, Texas, Illinois, and Florida each apply different rules; these are states with large concentrations of talc claimants. Some states recognize a “discovery of causation” rule that further extends the window to the point when the plaintiff could have reasonably connected the product to the diagnosis.

In my experience reviewing cases like this, the pattern I see repeatedly is a claimant who spent years watching news coverage of the litigation, assuming it was “for other people,” before finally consulting an attorney, who then found that the filing window was still open. The opposite also happens: people who delay past the deadline when they had grounds to file earlier. The only way to know for certain is to get a specific assessment of your state’s rules and your diagnosis date.

Wrongful Death Lawsuit Settlement →

What Documents You Will Need

Talc product liability claims are document-intensive. Beginning to gather records before you consult an attorney will make the initial consultation more productive.

Medical records: Diagnosis records, pathology reports, surgical notes, oncology treatment records. If you were diagnosed at multiple facilities, you will need records from each.

Product use history: While you cannot produce receipts from 1985, a written narrative of what products you used, when, for how long, and in what manner is valuable. Specific product names (Baby Powder versus Shower to Shower, for example) may matter because J&J sold multiple talc-based products with different formulations over time.

Exposure history: Whether you had other potential exposure to asbestos (occupational, environmental) will be relevant, particularly for mesothelioma claims where defendants commonly argue alternative causation.

Financial impact documentation: Treatment costs, lost wages, long-term care expenses. These form the basis of economic damages calculations.

Attorneys handling talc cases typically accept them on a contingency fee basis: no upfront cost, with the attorney’s fee paid as a percentage of any recovery. This means the financial barrier to an initial consultation is low, and a consultation costs nothing.

Asbestos Testing: The Ongoing Scientific Dispute

One reason the J&J litigation has remained contested for so long is the technical dispute over how talc products should be tested for asbestos contamination. Talc and asbestos minerals can be geologically co-located, and the question of whether trace levels of asbestos were present in J&J’s finished products has been addressed through different testing methodologies, leading to different results.

J&J has historically relied on testing methods it argues demonstrate the absence of asbestos. Plaintiffs’ experts have argued that more sensitive detection methods reveal contamination. This methodological dispute has played out in expert witness hearings (Daubert proceedings) within the MDL.

The FDA has conducted its own testing of cosmetic talc products. For current FDA guidance on talc safety, testing methodology, and any ongoing review, go directly to fda.gov rather than relying on third-party characterizations of what the FDA has found or not found. The agency’s position on talc has evolved as testing methods and available evidence have changed.

This is worth understanding as background because it helps explain why J&J has maintained such vigorous litigation defenses rather than settling quickly: the company argues that the science does not support causal conclusions. Whether that argument ultimately prevails in any given case is a question for juries and, ultimately, appellate courts.

Regulatory Context: What the FDA Has Said

For claimants who want to understand the regulatory background, the FDA has reviewed the safety of cosmetic talc products on multiple occasions. The FDA’s advisory materials and any safety communications are publicly available at fda.gov. Readers should check current FDA guidance directly rather than relying on third-party summaries, as the agency’s position and ongoing reviews evolve.

The FDA has not banned cosmetic talc products outright, but it has noted that current testing methods may not reliably detect low levels of asbestos contamination. This regulatory history has been relevant in litigation arguments about what J&J knew and when.

Medical Malpractice Birth Injury →

Next Steps

If you believe you may have a talc-related claim, here is a practical sequence:

1. Identify your diagnosis date and state of residence at diagnosis. These two facts determine your statute of limitations deadline more than anything else.

2. Consult a product liability attorney. Initial consultations are typically free. Look for attorneys with MDL talc experience; many have handled hundreds of similar cases and can quickly assess whether your situation falls within the current filing window. The fee agreement should be contingency-based and in writing.

3. Preserve all relevant records. Do not discard old products, receipts, or medical documents. If you have any existing containers of talc-based products, retain them.

4. Monitor litigation status. The PACER federal court database (pacer.gov) contains all public filings in MDL 2738. For a plain-language summary of where the litigation stands, SEC filings by Johnson & Johnson (available at sec.gov) discuss the company’s disclosed litigation exposure as a material risk.

5. Verify independently. Press coverage commonly references settlement negotiations and individual verdict ranges that vary widely. For accurate current information, go directly to justice.gov for any government-side communications, PACER for court filings, and the FDA website for regulatory context.

The J&J talc litigation is not over. If you have been diagnosed with ovarian cancer or mesothelioma and have a history of significant talc product use, an initial attorney consultation (which costs nothing) is the only reliable way to know whether a claim is available to you.